Skip to content

Cognitive effects of electrical current therapy in post-stroke depression: a study protocol for a randomized controlled trial

Cognitive effects of electrical current therapy in post-stroke depression: a study protocol for a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029809
Enrollment
Unknown
Registered
2020-02-14
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Stroke Depression

Interventions

Group A:Active tDCS/Placebo pill
Group B:Sham tDCS/escitaplopram
Group C:Sham tDCS/Placebo pill

Sponsors

Shanghai Seventh People's Hospital, Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Between 18 and 75 years of age with no gender-based restriction; 2. First or recurrent ischemic stroke that was confirmed by brain CT or MRI; 3. A minimum of 3 months and a maximum of 5-years post-stroke; 4. The Diagnostic and Statistical Manual of Mental Disorders version 5 (DSM-V) diagnosis for depression due to stroke 5. 17-item Hamilton Depression Rating Scale (HDRS-17) score greater than or equal to 17 points and less than 24 (24 > HDRS-17 >= 17); 6. Patients willing to participate in the RCT and sign informed consent forms; 7. Right-handedness.

Exclusion criteria

Exclusion criteria: 1. Individuals with any lifetime history of depression, anxiety, bipolar disorder, schizophrenia, etc. 2. Individuals with substance abuse, panic disorder, or post-traumatic stress disorder in the past 6 months prior to admission of stroke; 3. A high risk of attempting suicide (a score of more than 2 points on the third question (Suicide) of the HDRS-17) 4. Aphasia and severe cognitive impairment (MMSE scores<10 points). 5. Presence of other mental disorders (such as adaptation disorders) caused by substance abuse (such as medication, drug addiction, alcoholism) 6. Current or prior any psychological intervention for any reason. 7. Participation in another clinical trial 8. Currently Pregnant or breast-feeding

Design outcomes

Primary

MeasureTime frame
HRSD, MMSE and MoCA scores;

Secondary

MeasureTime frame
Zung Self-Rating Depression Scale, Barthel index, mBDNF/proBDNF, IFN- ?/IL-10;

Countries

China

Contacts

Public ContactZhenxiang Han

Shanghai Seventh People's Hospital, Shanghai University of TCM

hanxiang798007@163.com+86 17701767768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026